Drugs / Rotarix Porcine Circovirus (PCV)-Free Liquid
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06025695 | Sep 2023 → May 2024 | gastroenteritis | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Rotarix Porcine Circovirus (PCV)-Free Liquid | “Immunogenicity, Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Rotarix Porcine Circovirus (PCV)-Free Liquid Compared to Rotarix Liquid Given in 2-doses in...” NCT06025695 ↗ |
| Route | Oral | “administered orally at Day 1 and Month 1” NCT06025695 ↗ |